Cargando…
Expanding the phenotypic spectrum of KCNK4: From syndromic neurodevelopmental disorder to rolandic epilepsy
The KCNK4 gene, predominantly distributed in neurons, plays an essential role in controlling the resting membrane potential and regulating cellular excitability. Previously, only two variants were identified to be associated with human disease, facial dysmorphism, hypertrichosis, epilepsy, intellect...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851069/ https://www.ncbi.nlm.nih.gov/pubmed/36683851 http://dx.doi.org/10.3389/fnmol.2022.1081097 |
_version_ | 1784872330238885888 |
---|---|
author | Yan, Hong-Jun He, Yun-yan Jin, Liang Guo, Qiang Zhou, Jing-Hua Luo, Sheng |
author_facet | Yan, Hong-Jun He, Yun-yan Jin, Liang Guo, Qiang Zhou, Jing-Hua Luo, Sheng |
author_sort | Yan, Hong-Jun |
collection | PubMed |
description | The KCNK4 gene, predominantly distributed in neurons, plays an essential role in controlling the resting membrane potential and regulating cellular excitability. Previously, only two variants were identified to be associated with human disease, facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth (FHEIG) syndrome. In this study, we performed trio-based whole exon sequencing (WES) in a cohort of patients with epilepsy. Two de novo likely pathogenic variants were identified in two unrelated cases with heterogeneous phenotypes, including one with Rolandic epilepsy and one with the FHEIG syndrome. The two variants were predicted to be damaged by the majority of in silico algorithms. These variants showed no allele frequencies in controls and presented statistically higher frequencies in the case cohort than that in controls. The FHEIG syndrome-related variants were all located in the region with vital functions in stabilizing the conductive conformation, while the Rolandic epilepsy-related variant was distributed in the area with less impact on the conductive conformation. This study expanded the genetic and phenotypic spectrum of KCNK4. Phenotypic variations of KCNK4 are potentially associated with the molecular sub-regional effects. Carbamazepine/oxcarbazepine and valproate may be effective antiepileptic drugs for patients with KCNK4 variants. |
format | Online Article Text |
id | pubmed-9851069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98510692023-01-20 Expanding the phenotypic spectrum of KCNK4: From syndromic neurodevelopmental disorder to rolandic epilepsy Yan, Hong-Jun He, Yun-yan Jin, Liang Guo, Qiang Zhou, Jing-Hua Luo, Sheng Front Mol Neurosci Molecular Neuroscience The KCNK4 gene, predominantly distributed in neurons, plays an essential role in controlling the resting membrane potential and regulating cellular excitability. Previously, only two variants were identified to be associated with human disease, facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth (FHEIG) syndrome. In this study, we performed trio-based whole exon sequencing (WES) in a cohort of patients with epilepsy. Two de novo likely pathogenic variants were identified in two unrelated cases with heterogeneous phenotypes, including one with Rolandic epilepsy and one with the FHEIG syndrome. The two variants were predicted to be damaged by the majority of in silico algorithms. These variants showed no allele frequencies in controls and presented statistically higher frequencies in the case cohort than that in controls. The FHEIG syndrome-related variants were all located in the region with vital functions in stabilizing the conductive conformation, while the Rolandic epilepsy-related variant was distributed in the area with less impact on the conductive conformation. This study expanded the genetic and phenotypic spectrum of KCNK4. Phenotypic variations of KCNK4 are potentially associated with the molecular sub-regional effects. Carbamazepine/oxcarbazepine and valproate may be effective antiepileptic drugs for patients with KCNK4 variants. Frontiers Media S.A. 2023-01-05 /pmc/articles/PMC9851069/ /pubmed/36683851 http://dx.doi.org/10.3389/fnmol.2022.1081097 Text en Copyright © 2023 Yan, He, Jin, Guo, Zhou and Luo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Neuroscience Yan, Hong-Jun He, Yun-yan Jin, Liang Guo, Qiang Zhou, Jing-Hua Luo, Sheng Expanding the phenotypic spectrum of KCNK4: From syndromic neurodevelopmental disorder to rolandic epilepsy |
title | Expanding the phenotypic spectrum of KCNK4: From syndromic neurodevelopmental disorder to rolandic epilepsy |
title_full | Expanding the phenotypic spectrum of KCNK4: From syndromic neurodevelopmental disorder to rolandic epilepsy |
title_fullStr | Expanding the phenotypic spectrum of KCNK4: From syndromic neurodevelopmental disorder to rolandic epilepsy |
title_full_unstemmed | Expanding the phenotypic spectrum of KCNK4: From syndromic neurodevelopmental disorder to rolandic epilepsy |
title_short | Expanding the phenotypic spectrum of KCNK4: From syndromic neurodevelopmental disorder to rolandic epilepsy |
title_sort | expanding the phenotypic spectrum of kcnk4: from syndromic neurodevelopmental disorder to rolandic epilepsy |
topic | Molecular Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851069/ https://www.ncbi.nlm.nih.gov/pubmed/36683851 http://dx.doi.org/10.3389/fnmol.2022.1081097 |
work_keys_str_mv | AT yanhongjun expandingthephenotypicspectrumofkcnk4fromsyndromicneurodevelopmentaldisordertorolandicepilepsy AT heyunyan expandingthephenotypicspectrumofkcnk4fromsyndromicneurodevelopmentaldisordertorolandicepilepsy AT jinliang expandingthephenotypicspectrumofkcnk4fromsyndromicneurodevelopmentaldisordertorolandicepilepsy AT guoqiang expandingthephenotypicspectrumofkcnk4fromsyndromicneurodevelopmentaldisordertorolandicepilepsy AT zhoujinghua expandingthephenotypicspectrumofkcnk4fromsyndromicneurodevelopmentaldisordertorolandicepilepsy AT luosheng expandingthephenotypicspectrumofkcnk4fromsyndromicneurodevelopmentaldisordertorolandicepilepsy |